GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guanze Medical Information Industry (Holding) Co 2427.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.13

0.00%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Guanze Medical Information Industry (Holding) Co

Its shares trade on HKEX under the ticker 2427.HK. It has been listed since 29 December 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥88.4m and a net loss of CN¥29.7m. At that date it held total assets of CN¥270.7m and shareholders' equity of CN¥231.4m.

Guanze Medical Information Industry (Holding) Co., Ltd. is an investment company. The company is headquartered in Jinan, Shandong. The company went IPO on 2022-12-29. The firm is principally engaged in the provision of medical imaging film products and medical imaging cloud services. The firm sells medical imaging films procured from international brands and under own brand to hospitals and healthcare institutions. The medical imaging cloud services include digital medical imaging cloud storage platform, digital medical image platform, regional imaging diagrams platform and Picture Archiving and Communication System (PACS). The firm also engages in the sale of self-service film output printer, medical image printer and medical image data distribution system, as well as the maintenance and leasing of medical devices.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
29 Dec 2022
Employees
49

Leadership

Pay as last reported

  • Mr. Xianzhen MengExecutive Chairman of the Board, Chief Executive Officer, since 2020CN¥120,000
  • Mr. Tao LuChief Financial Officer
  • Mr. Zhenyu GuoExecutive Director, Chief Sales Officer, since 2021CN¥114,000
  • Ms. Yanying LunBusiness Manager
  • Mr. Fei WangChief Technical Officer
  • Mr. Senquan ZhangCompany Secretary
  • Ms. Cathy MengNon-Executive Director
  • Dr. Shiwang ChangNon-Executive Independent Director
  • Dr. Man Hin WongNon-Executive Independent Director
  • Dr. Bin ZhaoNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Guanze Medical Information Industry (Holding) Co Ltd provides medical imaging cloud services including PACS and regional imaging platforms.
  • The company sells medical imaging films from international brands and its own brand to hospitals.
  • Guanze employs 49 full-time employees and operates in the Health Care sector in Jinan, CN.

Weaknesses

  • Guanze Medical Information Industry (Holding) Co Ltd has only 49 employees, which may limit operational capacity.
  • The company's business is focused on medical imaging films and cloud services in the Health Care sector.
  • Guanze's IPO was on 29 December 2022, indicating a relatively new market presence.

Opportunities

  • Guanze can expand its medical imaging cloud services to more hospitals in Shandong Province.
  • The company can leverage its own brand for medical imaging films to increase market share.
  • Guanze may grow by offering self-service film output printers to healthcare institutions.

Threats

  • Guanze faces competition from international brands in the medical imaging film market.
  • The Health Care sector in China may face regulatory changes affecting medical imaging services.
  • Guanze's reliance on medical imaging cloud services could be impacted by technological shifts.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.